Dicerna Pharmaceuticals, Inc.(DRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DRNA Dicerna Pharmaceuticals, Inc.

停牌 11-19 19:39:02 EST

38.22

+0.00

0.00%

最高38.22	最低38.22	成交量0.00
今开38.22	昨收38.22	日振幅0.00%
总市值29.86亿	流通市值23.07亿	总股本7,813万
成交额2.13亿	换手率0.00%	流通股本6,036万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DRNA","market":"US","secType":"STK","nameCN":"Dicerna Pharmaceuticals, Inc.","latestPrice":38.22,"timestamp":1640638800000,"preClose":38.22,"halted":3,"volume":0,"delay":0,"floatShares":60363968,"shares":78129378,"eps":-1.625792,"marketStatus":"停牌","marketStatusCode":4,"change":0,"latestTime":"11-19 19:39:02 EST","open":38.22,"high":38.22,"low":38.22,"amount":212879611.474695,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.625792,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732064400000},"adr":0,"listingDate":1391058000000,"adjPreClose":38.22,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/DRNA","defaultTab":"news","newsList":[{"id":"2184895806","title":"Dicerna Pharmaceuticals, Inc.股价上涨78.41% 市值涨23.19亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2184895806","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2184895806?lang=zh_cn&edition=full","pubTime":"2021-11-18 22:31","pubTimestamp":1637245862,"startTime":"0","endTime":"0","summary":"北京时间2021年11月18日22时31分，Dicerna Pharmaceuticals, Inc.股票出现波动，股价大幅上涨78.41%。Dicerna Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Dicerna Pharmaceuticals, Inc.公司简介：Dicerna Pharmaceuticals 是一家生物技术公司，致力于发现和开发影响肝脏、心血管疾病、癌症和其他肝脏问题的罕见遗传疾病的创新疗法。","market":"us","thumbnail":"https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5caed408891c5ae9176e1a31289a0785"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111182231027a0c39e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111182231027a0c39e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CRCT","BK4209","OLPX","BK4191","BK4183","DRNA","HCTI","TERN","FWRG","ALVU","BK4167","BK4539"],"gpt_icon":0},{"id":"2162078983","title":"Dicerna Pharmaceuticals Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2162078983","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2162078983?lang=zh_cn&edition=full","pubTime":"2021-08-27 23:05","pubTimestamp":1630076703,"startTime":"0","endTime":"0","summary":"北京时间2021年08月27日23时05分，Dicerna Pharmaceuticals Inc.股票出现波动，股价快速拉升5.00%。截至发稿，该股报21.12美元/股，成交量22.899万股，换手率0.29%，振幅5.89%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Dicerna Pharmaceuticals Inc.公司简介：Dicerna Pharmaceuticals Inc是一家生物技术公司，致力于发现和开发影响肝脏的罕见遗传疾病的创新疗法，以及癌症和其他治疗领域，以解决肝脏问题。","market":"us","thumbnail":"https://static.tigerbbs.com/bd3ac286c2233d10a592ba6c388667fb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bd3ac286c2233d10a592ba6c388667fb"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021082723050477ee6d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021082723050477ee6d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRCT","DRNA","TERN"],"gpt_icon":0},{"id":"2158071244","title":"高盛将Dicerna(DRNA)的评级从买入下调至中性","url":"https://stock-news.laohu8.com/highlight/detail?id=2158071244","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2158071244?lang=zh_cn&edition=full","pubTime":"2021-08-11 14:27","pubTimestamp":1628663233,"startTime":"0","endTime":"0","summary":"凤凰网港股|高盛分析师Madhu Kumar将Dicerna(DRNA)的评级从买入下调至中性，目标价为25美元，低于36美元。该分析师指出，乳酸脱氢酶A RNAi药物nedosiran在治疗原发性高氧尿症的3期PHYOX2试验中出现了适度的临床活动，α-1抗胰蛋白酶RNAi药物belcesiran在治疗AAT PiZZ肝病的1期研究中也出现了临床活动，同时股价缺乏短期的催化途径。","market":"hk","thumbnail":"https://static.tigerbbs.com/8e87285f5f61644eaba65898e6ccf2bf","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8e87285f5f61644eaba65898e6ccf2bf"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=1f6f822728d03d7451c3dfbaa4f69f82","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRNA"],"gpt_icon":0},{"id":"2157328493","title":"Dicerna Pharmaceuticals Inc.股价重挫35.21% 市值跌6.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2157328493","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2157328493?lang=zh_cn&edition=full","pubTime":"2021-08-06 21:31","pubTimestamp":1628256678,"startTime":"0","endTime":"0","summary":"北京时间2021年08月06日21时31分，Dicerna Pharmaceuticals Inc.股票出现波动，股价急速下挫35.21%。截至发稿，该股报24.57美元/股，成交量38.9557万股，换手率0.51%，振幅6.39%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts、Athersys Inc、Aurinia Pharmaceuticals Inc涨幅较大，Cytogen Corp.、Ocuphire Pharma Inc、Nabriva Therapeutics Plc较为活跃，换手率分别为7.31%、2.70%、2.62%，振幅较大的相关个股有Collplant Biotechnologies Ltd、Dicerna Pharmaceuticals Inc.、Foghorn Therapeutics Inc，振幅分别为9.89%、6.39%、5.92%。","market":"us","thumbnail":"https://static.tigerbbs.com/28009f8e87ba9680b5b94d59ba7ac119","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/28009f8e87ba9680b5b94d59ba7ac119"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021080621311879ddc008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021080621311879ddc008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRCT","DRNA","TERN"],"gpt_icon":0},{"id":"2153649202","title":"Dicerna(DRNA)宣布belcesiran与AATLD试验的中期结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2153649202","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2153649202?lang=zh_cn&edition=full","pubTime":"2021-07-21 22:16","pubTimestamp":1626877008,"startTime":"0","endTime":"0","summary":"在这项分析中，belcesiran被认为具有可接受的安全性，而且普遍具有良好的耐受性。1期试验中belcesiran的最终剂量组的主要治疗评估期正在进行。除了证明belcesiran具有良好的耐受性之外，这项研究的结果还表明belcesiran有可能有意义地减少异常AAT蛋白的产生--这是开发AATLD患者药物干预的一个关键目标。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=d1101cd0ccd519c6fe1a7e981656d70e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRNA"],"gpt_icon":0},{"id":"2134693335","title":"Dicerna Pharmaceuticals Inc.盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2134693335","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2134693335?lang=zh_cn&edition=full","pubTime":"2021-05-12 01:11","pubTimestamp":1620753062,"startTime":"0","endTime":"0","summary":"北京时间2021年05月12日01时11分，Dicerna Pharmaceuticals Inc.股票出现异动，股价急速上涨5.06%。截至发稿，该股报27.21美元/股，成交量41.3133万股，换手率0.54%，振幅9.25%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Dicerna Pharmaceuticals Inc.公司简介：Dicerna Pharmaceuticals Inc是一家生物技术公司，致力于发现和开发影响肝脏的罕见遗传疾病的创新疗法，以及癌症和其他治疗领域，以解决肝脏问题。","market":"us","thumbnail":"https://static.tigerbbs.com/cb94707725a5c97e34b5305626765aec","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb94707725a5c97e34b5305626765aec"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202105120111027e6e422b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202105120111027e6e422b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRCT","DRNA","TERN"],"gpt_icon":0},{"id":"2129809534","title":"Dicerna Pharmaceuticals Inc.盘中异动 早盘大幅下跌5.09%报28.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2129809534","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2129809534?lang=zh_cn&edition=full","pubTime":"2021-04-21 22:42","pubTimestamp":1619016145,"startTime":"0","endTime":"0","summary":"北京时间2021年04月21日22时42分，Dicerna Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.09%。截至发稿，该股报28.91美元/股，成交量19.6328万股，换手率0.26%，振幅4.89%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Outlook Therapeutics Inc、阿索尔达生物制药公司、Eyenovia Inc涨幅较大，Alterity Therapeutics Limited、Ocugen Inc、Hoth Therapeutics Inc较为活跃，换手率分别为134.26%、37.39%、8.24%，振幅较大的相关个股有Biovie Inc、阿索尔达生物制药公司、Cassava Sciences Inc，振幅分别为19.88%、15.66%、14.62%。","market":"us","thumbnail":"https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202104212242257c0ae451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202104212242257c0ae451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRNA","CRCT","TERN"],"gpt_icon":0},{"id":"2128985930","title":"Dicerna Pharmaceuticals Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2128985930","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2128985930?lang=zh_cn&edition=full","pubTime":"2021-04-16 21:31","pubTimestamp":1618579899,"startTime":"0","endTime":"0","summary":"北京时间2021年04月16日21时31分，Dicerna Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报29.97美元/股，成交量6.6892万股，换手率0.09%，振幅1.07%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Iovance Biotherapeutics Inc、F-Star Therapeutics Inc、Aligos Therapeutics Inc涨幅较大，Iterum Therapeutics Plc、Millendo Therapeutics Inc、Ocugen Inc较为活跃，换手率分别为0.93%、0.81%、0.76%，振幅较大的相关个股有180 Life Sciences Corp、Synlogic Inc、Avidity Biosciences Inc，振幅分别为7.17%、6.33%、6.28%。","market":"us","thumbnail":"https://static.tigerbbs.com/f73e1c908efc5972b5b6e484e19b0d22","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f73e1c908efc5972b5b6e484e19b0d22"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210416213140774b991e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20210416213140774b991e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRCT","TERN","DRNA"],"gpt_icon":0},{"id":"2125762380","title":"Dicerna Pharmaceuticals Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2125762380","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2125762380?lang=zh_cn&edition=full","pubTime":"2021-04-05 22:22","pubTimestamp":1617632521,"startTime":"0","endTime":"0","summary":"北京时间2021年04月05日22时22分，Dicerna Pharmaceuticals Inc.股票出现波动，股价急速上涨5.20%。截至发稿，该股报27.10美元/股，成交量12.8178万股，换手率0.17%，振幅3.39%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Greenwich Lifesciences Inc、Bio-Path Holdings Inc、Virpax Pharmaceuticals, Inc.涨幅较大，Bio-Path Holdings Inc、Seneca Biopharma Inc、BriaCell Therapeutics Corp较为活跃，换手率分别为245.48%、12.12%、12.08%，振幅较大的相关个股有Bio-Path Holdings Inc、Virpax Pharmaceuticals, Inc.、LAVA Therapeutics NV，振幅分别为27.69%、17.41%、16.23%。","market":"us","thumbnail":"https://static.tigerbbs.com/60ffa9c348f2ccdef831ec338d80994f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/60ffa9c348f2ccdef831ec338d80994f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202104052222017d3e8266&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202104052222017d3e8266&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRNA","CRCT","TERN"],"gpt_icon":0},{"id":"2116557582","title":"Dicerna Pharmaceuticals Inc.盘中异动 急速拉升6.75%报28.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2116557582","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2116557582?lang=zh_cn&edition=full","pubTime":"2021-03-01 22:31","pubTimestamp":1614609100,"startTime":"0","endTime":"0","summary":"北京时间2021年03月01日22时31分，Dicerna Pharmaceuticals Inc.股票出现异动，股价急速拉升6.75%。截至发稿，该股报28.80美元/股，成交量5.6784万股，换手率0.07%，振幅4.37%。Dicerna Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Aslan Pharmaceuticals Limited、Morphic Holding Inc、Satsuma Pharmaceuticals Inc涨幅较大，BriaCell Therapeutics Corp、Aslan Pharmaceuticals Limited、Nabriva Therapeutics Plc较为活跃，换手率分别为179.20%、34.72%、8.09%，振幅较大的相关个股有Salarius Pharmaceuticals Inc、Poseida Therapetuics Inc、Repare Therapeutics Inc，振幅分别为14.17%、12.32%、10.90%。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021030122314079b4f4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021030122314079b4f4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TERN","DRNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dicerna.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dicerna Pharmaceuticals, Inc.于2006年10月在特拉华州成立。 公司是有限的经营历史的临床前阶段生物制药公司。生物制药产品开发是一项高度投机事业，并涉及到一定程度的风险。该公司目前在临床试验中没有任何候选产品或经批准出售产品，并继续承担重要的研究和发展以及相关总务及管理费用。该公司预期在可预见的未来继续招致重大损失。即使它在未来实现盈利能力，它在以后各期也不能保持维持盈利。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.049367},{"month":2,"riseRate":0.625,"avgChangeRate":0.083362},{"month":3,"riseRate":0.375,"avgChangeRate":-0.019806},{"month":4,"riseRate":0.375,"avgChangeRate":-0.025624},{"month":5,"riseRate":0.375,"avgChangeRate":-0.039698},{"month":6,"riseRate":0.625,"avgChangeRate":0.065527},{"month":7,"riseRate":0.5,"avgChangeRate":-0.057112},{"month":8,"riseRate":0.25,"avgChangeRate":-0.073444},{"month":9,"riseRate":0.375,"avgChangeRate":0.14166},{"month":10,"riseRate":0.5,"avgChangeRate":-0.045933},{"month":11,"riseRate":0.875,"avgChangeRate":0.343596},{"month":12,"riseRate":0.375,"avgChangeRate":-0.022115}],"exchange":"NASDAQ","name":"Dicerna Pharmaceuticals, Inc.","nameEN":"Dicerna Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Dicerna Pharmaceuticals, Inc.(DRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Dicerna Pharmaceuticals, Inc.(DRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Dicerna Pharmaceuticals, Inc.,DRNA,Dicerna Pharmaceuticals, Inc.股票,Dicerna Pharmaceuticals, Inc.股票老虎,Dicerna Pharmaceuticals, Inc.股票老虎国际,Dicerna Pharmaceuticals, Inc.行情,Dicerna Pharmaceuticals, Inc.股票行情,Dicerna Pharmaceuticals, Inc.股价,Dicerna Pharmaceuticals, Inc.股市,Dicerna Pharmaceuticals, Inc.股票价格,Dicerna Pharmaceuticals, Inc.股票交易,Dicerna Pharmaceuticals, Inc.股票购买,Dicerna Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Dicerna Pharmaceuticals, Inc.(DRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Dicerna Pharmaceuticals, Inc.(DRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}